Showing results (11-20 of 44) with videos related to
Sort By:
Pageof 5
Cardiovascular Research|March 30, 2002
Chronic endothelin receptor blockade prevents renal vasoconstriction and sodium retention in rats with chronic heart failureShuang-Shuang Ding, Changbin Qiu, Patrick Hess, et al.The Journal of Pharmacology and Experimental Therapeutics|April 29, 2014
Macitentan does not interfere with hepatic bile salt transportAlexander Treiber, Päivi Äänismaa, Ruben de Kanter, et al.Bioorganic & Medicinal Chemistry Letters|August 2, 2015
Discovery of novel bridged tetrahydronaphthalene derivatives as potent T/L-type calcium channel blockersDorte Renneberg, Francis Hubler, Markus Rey, et al.Plos One|March 17, 2018
A fully automated image analysis method to quantify lung fibrosis in the bleomycin-induced rat modelShanon Seger, Manuel Stritt, Enrico Vezzali, et al.The Journal of Pharmacology and Experimental Therapeutics|February 23, 2017
Endothelin ETA Receptor Blockade, by Activating ETB Receptors, Increases Vascular Permeability and Induces Exaggerated Fluid RetentionMagali Vercauteren, Frederic Trensz, Anne Pasquali, et al.The Journal of Pharmacology and Experimental Therapeutics|February 25, 2011
The selective sphingosine 1-phosphate receptor 1 agonist ponesimod protects against lymphocyte-mediated tissue inflammationLuca Piali, Sylvie Froidevaux, Patrick Hess, et al.Journal of Cardiovascular Pharmacology|November 1, 2002
Combination of low-dose valsartan and enalapril improves endothelial dysfunction and coronary reserve in Nomega-nitro-L-arginine methyl ester-treated spontaneously hypertensive ratsMarc de Gasparo, Patrick Hess, Martine Clozel, et al.The Journal of Pharmacology and Experimental Therapeutics|May 7, 2017
Selexipag Active Metabolite ACT-333679 Displays Strong Anticontractile and Antiremodeling Effects but Low β-Arrestin Recruitment and Desensitization PotentialJohn Gatfield, Katalin Menyhart, Daniel Wanner, et al.Journal of Medicinal Chemistry|November 10, 2015
4-((R)-2-{[6-((S)-3-Methoxypyrrolidin-1-yl)-2-phenylpyrimidine-4-carbonyl]amino}-3-phosphonopropionyl)piperazine-1-carboxylic Acid Butyl Ester (ACT-246475) and Its Prodrug (ACT-281959), a Novel P2Y12 Receptor Antagonist with a Wider Therapeutic Window in the Rat Than ClopidogrelEva Caroff, Francis Hubler, Emmanuel Meyer, et al.Bioorganic & Medicinal Chemistry Letters|September 17, 2010
Piperidine-based renin inhibitors: upper chain optimizationOlivier Corminboeuf, Olivier Bezençon, Luboš Remeň, et al.Pageof 5